Maria-alexandra Papadimitriou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.

Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 24, 2026

Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression.

Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression.

Journal: The Journal of biological chemistry

Published: January 14, 2026

Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosis.

Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosis.

Journal: British journal of cancer

Published: September 16, 2025

Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Journal: International journal of cancer

Published: February 05, 2025

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

Journal: Blood cancer journal

Published: October 31, 2024

Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.

Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 23, 2024

Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.

Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.

Journal: British journal of haematology

Published: October 19, 2023

CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients.

CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients.

Journal: Molecular therapy. Oncology

Published: October 09, 2023

Cancer quiescence: non-coding RNAs in the spotlight.

Cancer quiescence: non-coding RNAs in the spotlight.

Journal: Trends in molecular medicine

Published: May 14, 2023

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.

Journal: Journal of translational medicine

Published: January 19, 2023

Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.

Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.

Journal: International journal of molecular sciences

Published: January 03, 2023

Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.

Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.

Journal: Clinical chemistry

Published: July 15, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026